Global Transdermal Drug Patches Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Page: 102

Published Date: 06 Jun 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Transdermal Drug Patches market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Transdermal Drug Patches size is estimated to be XX million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Transdermal Drug Patches market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Transdermal Drug Patches market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Fentanyl Transdermal Patch
    Nicotine Transdermal Patch
    Buprenorphine Transdermal Patch
    Clonidine Transdermal Patch
    Oxybutynin Transdermal Patch
    Others

Market segment by Application can be divided into
    Hypertension
    Contraception
    Analgesia
    Smoking Cessation
    Angina
    Hormone Replacement

The key market players for global Transdermal Drug Patches market are listed below:
    Noven
    Mylan
    Novartis
    Johnson & Johnson
    Agile Therapeutics
    Teikoku Pharma USA
    Immune Pharmaceuticals
    Hercon Pharmaceuticals
    Pocono
    DURECT Corporation
    Xel Pharmaceuticals

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Transdermal Drug Patches product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Transdermal Drug Patches, with price, sales, revenue and global market share of Transdermal Drug Patches from 2019 to 2021.
Chapter 3, the Transdermal Drug Patches competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Transdermal Drug Patches breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Transdermal Drug Patches market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Transdermal Drug Patches sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Transdermal Drug Patches Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Transdermal Drug Patches Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Fentanyl Transdermal Patch
        1.2.3 Nicotine Transdermal Patch
        1.2.4 Buprenorphine Transdermal Patch
        1.2.5 Clonidine Transdermal Patch
        1.2.6 Oxybutynin Transdermal Patch
        1.2.7 Others
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Transdermal Drug Patches Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Hypertension
        1.3.3 Contraception
        1.3.4 Analgesia
        1.3.5 Smoking Cessation
        1.3.6 Angina
        1.3.7 Hormone Replacement
    1.4 Global Transdermal Drug Patches Market Size & Forecast
        1.4.1 Global Transdermal Drug Patches Sales in Value (2016-2026))
        1.4.2 Global Transdermal Drug Patches Sales in Volume (2016-2026)
        1.4.3 Global Transdermal Drug Patches Price by Type (2016-2026) & (USD/K Units)
    1.5 Global Transdermal Drug Patches Production Capacity Analysis
        1.5.1 Global Transdermal Drug Patches Total Production Capacity (2016-2026)
        1.5.2 Global Transdermal Drug Patches Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Transdermal Drug Patches Market Drivers
        1.6.2 Transdermal Drug Patches Market Restraints
        1.6.3 Transdermal Drug Patches Trends Analysis

2 Manufacturers Profiles
    2.1 Noven
        2.1.1 Noven Details
        2.1.2 Noven Major Business
        2.1.3 Noven Transdermal Drug Patches Product and Services
        2.1.4 Noven Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 Mylan
        2.2.1 Mylan Details
        2.2.2 Mylan Major Business
        2.2.3 Mylan Transdermal Drug Patches Product and Services
        2.2.4 Mylan Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 Novartis
        2.3.1 Novartis Details
        2.3.2 Novartis Major Business
        2.3.3 Novartis Transdermal Drug Patches Product and Services
        2.3.4 Novartis Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 Johnson & Johnson
        2.4.1 Johnson & Johnson Details
        2.4.2 Johnson & Johnson Major Business
        2.4.3 Johnson & Johnson Transdermal Drug Patches Product and Services
        2.4.4 Johnson & Johnson Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 Agile Therapeutics
        2.5.1 Agile Therapeutics Details
        2.5.2 Agile Therapeutics Major Business
        2.5.3 Agile Therapeutics Transdermal Drug Patches Product and Services
        2.5.4 Agile Therapeutics Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.6 Teikoku Pharma USA
        2.6.1 Teikoku Pharma USA Details
        2.6.2 Teikoku Pharma USA Major Business
        2.6.3 Teikoku Pharma USA Transdermal Drug Patches Product and Services
        2.6.4 Teikoku Pharma USA Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.7 Immune Pharmaceuticals
        2.7.1 Immune Pharmaceuticals Details
        2.7.2 Immune Pharmaceuticals Major Business
        2.7.3 Immune Pharmaceuticals Transdermal Drug Patches Product and Services
        2.7.4 Immune Pharmaceuticals Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.8 Hercon Pharmaceuticals
        2.8.1 Hercon Pharmaceuticals Details
        2.8.2 Hercon Pharmaceuticals Major Business
        2.8.3 Hercon Pharmaceuticals Transdermal Drug Patches Product and Services
        2.8.4 Hercon Pharmaceuticals Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.9 Pocono
        2.9.1 Pocono Details
        2.9.2 Pocono Major Business
        2.9.3 Pocono Transdermal Drug Patches Product and Services
        2.9.4 Pocono Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.10 DURECT Corporation
        2.10.1 DURECT Corporation Details
        2.10.2 DURECT Corporation Major Business
        2.10.3 DURECT Corporation Transdermal Drug Patches Product and Services
        2.10.4 DURECT Corporation Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.11 Xel Pharmaceuticals
        2.11.1 Xel Pharmaceuticals Details
        2.11.2 Xel Pharmaceuticals Major Business
        2.11.3 Xel Pharmaceuticals Transdermal Drug Patches Product and Services
        2.11.4 Xel Pharmaceuticals Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Transdermal Drug Patches Sales by Manufacturer
    3.1 Global Transdermal Drug Patches Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Transdermal Drug Patches Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Transdermal Drug Patches
    3.4 Market Concentration Rate
        3.4.1 Top 3 Transdermal Drug Patches Manufacturer Market Share
        3.4.2 Top 6 Transdermal Drug Patches Manufacturer Market Share
    3.5 Global Transdermal Drug Patches Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Transdermal Drug Patches Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Transdermal Drug Patches Market Size by Region
        4.1.1 Global Transdermal Drug Patches Sales in Volume by Region (2016-2026)
        4.1.2 Global Transdermal Drug Patches Revenue by Region (2016-2026)
    4.2 North America Transdermal Drug Patches Revenue (2016-2026)
    4.3 Europe Transdermal Drug Patches Revenue (2016-2026)
    4.4 Asia-Pacific Transdermal Drug Patches Revenue (2016-2026)
    4.5 South America Transdermal Drug Patches Revenue (2016-2026)
    4.6 Middle East and Africa Transdermal Drug Patches Revenue (2016-2026)

5 Market Segment by Type
    5.1 Global Transdermal Drug Patches Sales in Volume by Type (2016-2026)
    5.2 Global Transdermal Drug Patches Revenue by Type (2016-2026)
    5.3 Global Transdermal Drug Patches Price by Type (2016-2026)

6 Market Segment by Application
    6.1 Global Transdermal Drug Patches Sales in Volume by Application (2016-2026)
    6.2 Global Transdermal Drug Patches Revenue by Application (2016-2026)
    6.3 Global Transdermal Drug Patches Price by Application (2016-2026)

7 North America by Country, by Type, and by Application
    7.1 North America Transdermal Drug Patches Sales by Type (2016-2026)
    7.2 North America Transdermal Drug Patches Sales by Application (2016-2026)
    7.3 North America Transdermal Drug Patches Market Size by Country
        7.3.1 North America Transdermal Drug Patches Sales in Volume by Country (2016-2026)
        7.3.2 North America Transdermal Drug Patches Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application
    8.1 Europe Transdermal Drug Patches Sales by Type (2016-2026)
    8.2 Europe Transdermal Drug Patches Sales by Application (2016-2026)
    8.3 Europe Transdermal Drug Patches Market Size by Country
        8.3.1 Europe Transdermal Drug Patches Sales in Volume by Country (2016-2026)
        8.3.2 Europe Transdermal Drug Patches Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Transdermal Drug Patches Sales by Type (2016-2026)
    9.2 Asia-Pacific Transdermal Drug Patches Sales by Application (2016-2026)
    9.3 Asia-Pacific Transdermal Drug Patches Market Size by Region
        9.3.1 Asia-Pacific Transdermal Drug Patches Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Transdermal Drug Patches Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application
    10.1 South America Transdermal Drug Patches Sales by Type (2016-2026)
    10.2 South America Transdermal Drug Patches Sales by Application (2016-2026)
    10.3 South America Transdermal Drug Patches Market Size by Country
        10.3.1 South America Transdermal Drug Patches Sales in Volume by Country (2016-2026)
        10.3.2 South America Transdermal Drug Patches Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Transdermal Drug Patches Sales by Type (2016-2026)
    11.2 Middle East & Africa Transdermal Drug Patches Sales by Application (2016-2026)
    11.3 Middle East & Africa Transdermal Drug Patches Market Size by Country
        11.3.1 Middle East & Africa Transdermal Drug Patches Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Transdermal Drug Patches Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Transdermal Drug Patches Typical Distributors
    12.3 Transdermal Drug Patches Typical Customers

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Transdermal Drug Patches Revenue by Type, (USD Million), 2021-2026
    Table 2. Global Transdermal Drug Patches Revenue by Application, (USD Million), 2021-2026
    Table 3. Noven Basic Information, Manufacturing Base and Competitors
    Table 4. Noven Major Business
    Table 5. Noven Transdermal Drug Patches Product and Services
    Table 6. Noven Transdermal Drug Patches Sales (K Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 7. Mylan Basic Information, Manufacturing Base and Competitors
    Table 8. Mylan Major Business
    Table 9. Mylan Transdermal Drug Patches Product and Services
    Table 10. Mylan Transdermal Drug Patches Sales (K Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 11. Novartis Basic Information, Manufacturing Base and Competitors
    Table 12. Novartis Major Business
    Table 13. Novartis Transdermal Drug Patches Product and Services
    Table 14. Novartis Transdermal Drug Patches Sales (K Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 15. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table 16. Johnson & Johnson Major Business
    Table 17. Johnson & Johnson Transdermal Drug Patches Product and Services
    Table 18. Johnson & Johnson Transdermal Drug Patches Sales (K Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 19. Agile Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 20. Agile Therapeutics Major Business
    Table 21. Agile Therapeutics Transdermal Drug Patches Product and Services
    Table 22. Agile Therapeutics Transdermal Drug Patches Sales (K Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 23. Teikoku Pharma USA Basic Information, Manufacturing Base and Competitors
    Table 24. Teikoku Pharma USA Major Business
    Table 25. Teikoku Pharma USA Transdermal Drug Patches Product and Services
    Table 26. Teikoku Pharma USA Transdermal Drug Patches Sales (K Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 27. Immune Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 28. Immune Pharmaceuticals Major Business
    Table 29. Immune Pharmaceuticals Transdermal Drug Patches Product and Services
    Table 30. Immune Pharmaceuticals Transdermal Drug Patches Sales (K Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 31. Hercon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 32. Hercon Pharmaceuticals Major Business
    Table 33. Hercon Pharmaceuticals Transdermal Drug Patches Product and Services
    Table 34. Hercon Pharmaceuticals Transdermal Drug Patches Sales (K Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 35. Pocono Basic Information, Manufacturing Base and Competitors
    Table 36. Pocono Major Business
    Table 37. Pocono Transdermal Drug Patches Product and Services
    Table 38. Pocono Transdermal Drug Patches Sales (K Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 39. DURECT Corporation Basic Information, Manufacturing Base and Competitors
    Table 40. DURECT Corporation Major Business
    Table 41. DURECT Corporation Transdermal Drug Patches Product and Services
    Table 42. DURECT Corporation Transdermal Drug Patches Sales (K Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 43. Xel Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 44. Xel Pharmaceuticals Major Business
    Table 45. Xel Pharmaceuticals Transdermal Drug Patches Product and Services
    Table 46. Xel Pharmaceuticals Transdermal Drug Patches Sales (K Units), Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 47. Global Transdermal Drug Patches Sales by Manufacturer (2019-2021e) & (K Units)
    Table 48. Global Transdermal Drug Patches Revenue by Manufacturer (2019-2021e) & (USD Million)
    Table 49. Market Position of Manufacturers in Transdermal Drug Patches, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
    Table 50. Global Transdermal Drug Patches Production Capacity by Company, (K Units): 2020 VS 2021
    Table 51. Head Office and Transdermal Drug Patches Production Site of Key Manufacturer
    Table 52. Transdermal Drug Patches New Entrant and Capacity Expansion Plans
    Table 53. Transdermal Drug Patches Mergers & Acquisitions in the Past Five Years
    Table 54. Global Transdermal Drug Patches Sales by Region (2016-2021e) & (K Units)
    Table 55. Global Transdermal Drug Patches Sales by Region (2021-2026) & (K Units)
    Table 56. Global Transdermal Drug Patches Revenue by Region (2016-2021e) & (USD Million)
    Table 57. Global Transdermal Drug Patches Revenue by Region (2021-2026) & (USD Million)
    Table 58. Global Transdermal Drug Patches Sales by Type (2016-2021e) & (K Units)
    Table 59. Global Transdermal Drug Patches Sales by Type (2021-2026) & (K Units)
    Table 60. Global Transdermal Drug Patches Revenue by Type (2016-2021e) & (USD Million)
    Table 61. Global Transdermal Drug Patches Revenue by Type (2021-2026) & (USD Million)
    Table 62. Global Transdermal Drug Patches Price by Type (2016-2021e) & (USD/K Units)
    Table 63. Global Transdermal Drug Patches Price by Type (2021-2026) & (USD/K Units)
    Table 64. Global Transdermal Drug Patches Sales by Application (2016-2021e) & (K Units)
    Table 65. Global Transdermal Drug Patches Sales by Application (2021-2026) & (K Units)
    Table 66. Global Transdermal Drug Patches Revenue by Application (2016-2021e) & (USD Million)
    Table 67. Global Transdermal Drug Patches Revenue by Application (2021-2026) & (USD Million)
    Table 68. Global Transdermal Drug Patches Price by Application (2016-2021e) & (USD/K Units)
    Table 69. Global Transdermal Drug Patches Price by Application (2021-2026) & (USD/K Units)
    Table 70. North America Transdermal Drug Patches Sales by Country (2016-2021e) & (K Units)
    Table 71. North America Transdermal Drug Patches Sales by Country (2021-2026) & (K Units)
    Table 72. North America Transdermal Drug Patches Revenue by Country (2016-2021e) & (USD Million)
    Table 73. North America Transdermal Drug Patches Revenue by Country (2021-2026) & (USD Million)
    Table 74. North America Transdermal Drug Patches Sales by Type (2016-2021e) & (K Units)
    Table 75. North America Transdermal Drug Patches Sales by Type (2021-2026) & (K Units)
    Table 76. North America Transdermal Drug Patches Sales by Application (2016-2021e) & (K Units)
    Table 77. North America Transdermal Drug Patches Sales by Application (2021-2026) & (K Units)
    Table 78. Europe Transdermal Drug Patches Sales by Country (2016-2021e) & (K Units)
    Table 79. Europe Transdermal Drug Patches Sales by Country (2021-2026) & (K Units)
    Table 80. Europe Transdermal Drug Patches Revenue by Country (2016-2021e) & (USD Million)
    Table 81. Europe Transdermal Drug Patches Revenue by Country (2021-2026) & (USD Million)
    Table 82. Europe Transdermal Drug Patches Sales by Type (2016-2021e) & (K Units)
    Table 83. Europe Transdermal Drug Patches Sales by Type (2021-2026) & (K Units)
    Table 84. Europe Transdermal Drug Patches Sales by Application (2016-2021e) & (K Units)
    Table 85. Europe Transdermal Drug Patches Sales by Application (2021-2026) & (K Units)
    Table 86. Asia-Pacific Transdermal Drug Patches Sales by Region (2016-2021e) & (K Units)
    Table 87. Asia-Pacific Transdermal Drug Patches Sales by Region (2021-2026) & (K Units)
    Table 88. Asia-Pacific Transdermal Drug Patches Revenue by Region (2016-2021e) & (USD Million)
    Table 89. Asia-Pacific Transdermal Drug Patches Revenue by Region (2021-2026) & (USD Million)
    Table 90. Asia-Pacific Transdermal Drug Patches Sales by Type (2016-2021e) & (K Units)
    Table 91. Asia-Pacific Transdermal Drug Patches Sales by Type (2021-2026) & (K Units)
    Table 92. Asia-Pacific Transdermal Drug Patches Sales by Application (2016-2021e) & (K Units)
    Table 93. Asia-Pacific Transdermal Drug Patches Sales by Application (2021-2026) & (K Units)
    Table 94. South America Transdermal Drug Patches Sales by Country (2016-2021e) & (K Units)
    Table 95. South America Transdermal Drug Patches Sales by Country (2021-2026) & (K Units)
    Table 96. South America Transdermal Drug Patches Revenue by Country (2016-2021e) & (USD Million)
    Table 97. South America Transdermal Drug Patches Revenue by Country (2021-2026) & (USD Million)
    Table 98. South America Transdermal Drug Patches Sales by Type (2016-2021e) & (K Units)
    Table 99. South America Transdermal Drug Patches Sales by Type (2021-2026) & (K Units)
    Table 100. South America Transdermal Drug Patches Sales by Application (2016-2021e) & (K Units)
    Table 101. South America Transdermal Drug Patches Sales by Application (2021-2026) & (K Units)
    Table 102. Middle East & Africa Transdermal Drug Patches Sales by Country (2016-2021e) & (K Units)
    Table 103. Middle East & Africa Transdermal Drug Patches Sales by Country (2021-2026) & (K Units)
    Table 104. Middle East & Africa Transdermal Drug Patches Revenue by Country (2016-2021e) & (USD Million)
    Table 105. Middle East & Africa Transdermal Drug Patches Revenue by Country (2021-2026) & (USD Million)
    Table 106. Middle East & Africa Transdermal Drug Patches Sales by Type (2016-2021e) & (K Units)
    Table 107. Middle East & Africa Transdermal Drug Patches Sales by Type (2021-2026) & (K Units)
    Table 108. Middle East & Africa Transdermal Drug Patches Sales by Application (2016-2021e) & (K Units)
    Table 109. Middle East & Africa Transdermal Drug Patches Sales by Application (2021-2026) & (K Units)
    Table 110. Direct Channel Pros & Cons
    Table 111. Indirect Channel Pros & Cons
    Table 112. Transdermal Drug Patches Typical Distributors
    Table 113. Transdermal Drug Patches Typical Customers
List of Figures
    Figure 1. Transdermal Drug Patches Picture
    Figure 2. Global Transdermal Drug Patches Sales Market Share by Type in 2020
    Figure 3. Fentanyl Transdermal Patch
    Figure 4. Nicotine Transdermal Patch
    Figure 5. Buprenorphine Transdermal Patch
    Figure 6. Clonidine Transdermal Patch
    Figure 7. Oxybutynin Transdermal Patch
    Figure 8. Others
    Figure 9. Global Transdermal Drug Patches Sales Market Share by Application in 2020
    Figure 10. Hypertension
    Figure 11. Contraception
    Figure 12. Analgesia
    Figure 13. Smoking Cessation
    Figure 14. Angina
    Figure 15. Hormone Replacement
    Figure 16. Global Transdermal Drug Patches Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
    Figure 17. Global Transdermal Drug Patches Market Size and Forecast (2016-2026) & (USD Million)
    Figure 18. Global Transdermal Drug Patches Sales (2016-2026) & (K Units)
    Figure 19. Global Transdermal Drug Patches Price by Type (2016-2026) & (USD/K Units)
    Figure 20. Global Transdermal Drug Patches Production Capacity (2016-2026) & (K Units)
    Figure 21. Global Transdermal Drug Patches Production Capacity by Geographic Region: 2020 VS 2021
    Figure 22. Transdermal Drug Patches Market Drivers
    Figure 23. Transdermal Drug Patches Market Restraints
    Figure 24. Transdermal Drug Patches Market Trends
    Figure 25. Global Transdermal Drug Patches Sales Market Share by Manufacturer in 2020
    Figure 26. Global Transdermal Drug Patches Revenue Market Share by Manufacturer in 2020
    Figure 27. Transdermal Drug Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    Figure 28. Top 3 Transdermal Drug Patches Manufacturer (Revenue) Market Share in 2020
    Figure 29. Top 6 Transdermal Drug Patches Manufacturer (Revenue) Market Share in 2020
    Figure 30. Global Transdermal Drug Patches Sales Market Share by Region (2016-2026)
    Figure 31. Global Transdermal Drug Patches Revenue Market Share by Region (2016-2026)
    Figure 32. North America Transdermal Drug Patches Revenue (2016-2026) & (USD Million)
    Figure 33. Europe Transdermal Drug Patches Revenue (2016-2026) & (USD Million)
    Figure 34. Asia-Pacific Transdermal Drug Patches Revenue (2016-2026) & (USD Million)
    Figure 35. South America Transdermal Drug Patches Revenue (2016-2026) & (USD Million)
    Figure 36. Middle East & Africa Transdermal Drug Patches Revenue (2016-2026) & (USD Million)
    Figure 37. Global Transdermal Drug Patches Sales Market Share by Type (2016-2026)
    Figure 38. Global Transdermal Drug Patches Revenue Market Share by Type (2016-2026)
    Figure 39. Global Transdermal Drug Patches Price by Type (2016-2026) & (USD/K Units)
    Figure 40. Global Transdermal Drug Patches Sales Market Share by Application (2016-2026)
    Figure 41. Global Transdermal Drug Patches Revenue Market Share by Application (2016-2026)
    Figure 42. Global Transdermal Drug Patches Price by Application (2016-2026) & (USD/K Units)
    Figure 43. North America Transdermal Drug Patches Sales Market Share by Type (2016-2026)
    Figure 44. North America Transdermal Drug Patches Sales Market Share by Application (2016-2026)
    Figure 45. North America Transdermal Drug Patches Sales Market Share by Country (2016-2026)
    Figure 46. North America Transdermal Drug Patches Revenue Market Share by Country (2016-2026)
    Figure 47. United States Transdermal Drug Patches Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 48. Canada Transdermal Drug Patches Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 49. Mexico Transdermal Drug Patches Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. Europe Transdermal Drug Patches Sales Market Share by Type (2016-2026)
    Figure 51. Europe Transdermal Drug Patches Sales Market Share by Application (2016-2026)
    Figure 52. Europe Transdermal Drug Patches Sales Market Share by Country (2016-2026)
    Figure 53. Europe Transdermal Drug Patches Revenue Market Share by Country (2016-2026)
    Figure 54. Germany Transdermal Drug Patches Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 55. France Transdermal Drug Patches Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 56. United Kingdom Transdermal Drug Patches Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. Russia Transdermal Drug Patches Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. Italy Transdermal Drug Patches Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. Asia-Pacific Transdermal Drug Patches Sales Market Share by Region (2016-2026)
    Figure 60. Asia-Pacific Transdermal Drug Patches Sales Market Share by Application (2016-2026)
    Figure 61. Asia-Pacific Transdermal Drug Patches Sales Market Share by Region (2016-2026)
    Figure 62. Asia-Pacific Transdermal Drug Patches Revenue Market Share by Region (2016-2026)
    Figure 63. China Transdermal Drug Patches Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. Japan Transdermal Drug Patches Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. Korea Transdermal Drug Patches Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. India Transdermal Drug Patches Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. Southeast Asia Transdermal Drug Patches Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. Australia Transdermal Drug Patches Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 69. South America Transdermal Drug Patches Sales Market Share by Type (2016-2026)
    Figure 70. South America Transdermal Drug Patches Sales Market Share by Application (2016-2026)
    Figure 71. South America Transdermal Drug Patches Sales Market Share by Country (2016-2026)
    Figure 72. South America Transdermal Drug Patches Revenue Market Share by Country (2016-2026)
    Figure 73. Brazil Transdermal Drug Patches Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. Argentina Transdermal Drug Patches Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 75. Middle East & Africa Transdermal Drug Patches Sales Market Share by Type (2016-2026)
    Figure 76. Middle East & Africa Transdermal Drug Patches Sales Market Share by Application (2016-2026)
    Figure 77. Middle East & Africa Transdermal Drug Patches Sales Market Share by Country (2016-2026)
    Figure 78. Middle East & Africa Transdermal Drug Patches Revenue Market Share by Country (2016-2026)
    Figure 79. Turkey Transdermal Drug Patches Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 80. Egypt Transdermal Drug Patches Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 81. Saudi Arabia Transdermal Drug Patches Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 82. South Africa Transdermal Drug Patches Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 83. Sales Channel: Direct Channel vs Indirect Channel
    Figure 84. Methodology
    Figure 85. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Noven
Mylan
Novartis
Johnson & Johnson
Agile Therapeutics
Teikoku Pharma USA
Immune Pharmaceuticals
Hercon Pharmaceuticals
Pocono
DURECT Corporation
Xel Pharmaceuticals

Related Reports

Global Transdermal Drug Patches Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Transdermal Drug Patches Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 04 Jan 2022

date Pharma & Healthcare

The Transdermal Drug Patches market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Transdermal Drug Patches Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Transdermal Drug Patches Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

Global Transdermal Drug Patches Supply, Demand and Key Producers, 2023-2029

Global Transdermal Drug Patches Supply, Demand and Key Producers, 2023-2029

date 12 Jan 2023

date Pharma & Healthcare

The global Transdermal Drug Patches market size is expected to reach $ 7952.9 million by 2029, rising at a market growth of 1.8% CAGR during the forecast period (2023-2029).

Global Transdermal Drug Patches Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Transdermal Drug Patches Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Transdermal Drug Patches market size was valued at USD 7028.9 million in 2023 and is forecast to a readjusted size of USD 7952.9 million by 2030 with a CAGR of 1.8% during review period.

Global Transdermal Drug Patches Supply, Demand and Key Producers, 2024-2030

Global Transdermal Drug Patches Supply, Demand and Key Producers, 2024-2030

date 20 Feb 2024

date Pharma & Healthcare

The global Transdermal Drug Patches market size is expected to reach $ 7952.9 million by 2030, rising at a market growth of 1.8% CAGR during the forecast period (2024-2030).

Product Tags

transdermal drug patches

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>